Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 851420
                    [Title] => Texas hospital plans 'moonshot' against cancer
                    [Summary] => 
The United States' largest cancer center is launching a massive "moonshot" effort against eight specific forms of the disease, similar to the all-out push for space exploration 50 years ago.
                    [DatePublished] => 2012-09-21 13:48:32
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. RONALD

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 851420
                    [Title] => Texas hospital plans 'moonshot' against cancer
                    [Summary] => 
The United States' largest cancer center is launching a massive "moonshot" effort against eight specific forms of the disease, similar to the all-out push for space exploration 50 years ago.
                    [DatePublished] => 2012-09-21 13:48:32
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 464588
                    [Title] => Reducing risk of cancer returning in patients
                    [Summary] => 
MANILA,  Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal tumors (GIST) compared with placebo.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Texas hospital plans 'moonshot' against cancer

September 21, 2012 - 1:48pm

The United States' largest cancer center is launching a massive "moonshot" effort against eight specific forms of the disease, similar to the all-out push for space exploration 50 years ago.

Reducing risk of cancer returning in patients

May 7, 2009 - 12:00am

MANILA, Philippines – Data published in the online edition of the Lancet show that imatinib, when taken after surgery, substantially reduces the rate of recurrence of Kit-positive gastrointestinal stromal...

Science and Environment